-
CheckOrphan is delighted to have arranged a special invitation and 15% discount for CheckOrphan readers who would like to attend Terrapinn’s World Orphan Drug Congress between 29 November &ndash 1...
» Read more
-
[if gte mso 10]> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"" mso...
» Read more
-
MIT student Gabe Blanchet is hiking the Appalachian Trail and blogging about his experience. Here is his latest entry.Home sweet home! I’ve trekked over 1,500 miles now into Massachusetts! 680 remain...
» Read more
-
For many people with mysterious conditions, the Undiagnosed Diseases Program (UDP) is their last hope. Founded in 2008, the UDP is a clinical research program of the United States' National Institutes of...
» Read more
-
We wrote earlier this year about Tarsila, a little Brazilian girl with a long and complicated medical history (post here. Tomorrow, October 14, Tarsila turns two. She now has five teeth, and lately sh e...
» Read more
-
Celebrated on October 10, the World Mental Health Day was started in 1992 by the World Federation for Mental Health. It aims to be an unified effort to promote greater public awareness and understandi ng...
» Read more
-
The U.S. Food and Drug Administration (FDA) has announced its approval of Gilenya(TM) (fingolimod), the first oral treatment for relapsing forms of multiple sclerosis (MS).In patients treated with Gil enya...
» Read more
-
Tomorrow, September 26th, the first ever Mesothelioma Awareness Day will be held all over the United States. The event aims to spread awareness about the most aggressive and deadly of asbestos-related diseases...
» Read more
-
The Pepsi Refresh Project is a grants scheme providing millions of dollars to fund good ideas, big and small, that make the world a better place. Each month, one thousand ideas are selected and the pu blic...
» Read more
-
The United States Orphan Drug Act (US ODA) was passed in 1983, as way to stimulate the development of new therapies for rare diseases. According to the US ODA, orphan drugs are promising therapies int ended...
» Read more